Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Gladstone Institutes

Gladstone Institutes fights cancer by harnessing the power of genomics and CRISPR technologies to program the immune system

At the Gladstone-UCSF Institute of Genomic Immunology, experts in immunology, synthetic biology, human genetics and CRISPR genome engineering are joining forces to push the boundaries of what’s possible. To overcome cancer, they are learning how to precisely control human immune cells and re-engineer them to become living and genetically-programmable drugs. Investigators at the Parker Institute for Cancer Immunotherapy at Gladstone Institutes are using the latest genomic technologies to understand what governs the function of immune cells and help design next-generation immunotherapy approaches for clinical translation.

Alexander Marson, MD, PhD | Director